» Authors » Zijuan Hu

Zijuan Hu

Explore the profile of Zijuan Hu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 140
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhong X, Wang Y, He X, He X, Hu Z, Huang H, et al.
Cell Death Dis . 2024 Sep; 15(9):645. PMID: 39227375
lncRNA can regulate tumorigenesis development and distant metastasis of colorectal cancer (CRC). However, the detailed molecular mechanisms are still largely unknown. Using RNA-sequencing data, RT-qPCR, and FISH assay, we found...
2.
Huang H, Chen K, Zhu Y, Hu Z, Wang Y, Chen J, et al.
J Transl Med . 2024 Feb; 22(1):211. PMID: 38419085
Background: Lactylation, a novel contributor to post-translational protein modifications, exhibits dysregulation across various tumors. Nevertheless, its intricate involvement in colorectal carcinoma, particularly for non-histone lactylation and its intersection with metabolism...
3.
He X, Zhong X, Fang Y, Hu Z, Chen Z, Wang Y, et al.
Clin Transl Med . 2023 Aug; 13(8):e1352. PMID: 37565737
Background: The tumourigenesis of various cancers is influenced by epigenetic deregulation. Among 591 epigenetic regulator factors (ERFs) examined, AF9 showed significant inhibition of malignancy in colorectal cancer (CRC) based on...
4.
Wang Y, Zhong X, He X, Hu Z, Huang H, Chen J, et al.
J Exp Clin Cancer Res . 2023 Jul; 42(1):177. PMID: 37480104
Colorectal cancer liver metastasis (CRLM) is one of the leading causes of death among patients with colorectal cancer (CRC). Although immunotherapy has demonstrated encouraging outcomes in CRC, its benefits are...
5.
He X, Chen H, Zhong X, Wang Y, Hu Z, Huang H, et al.
Int J Biol Sci . 2023 Jan; 19(1):331-345. PMID: 36594082
Tumor-associated macrophages (TAMs) are one of the most prominent tumor-infiltrating immune cells in the tumor microenvironment (TME) of CRC and play a vital role in the progression of CRC. BST2...
6.
Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao S, et al.
J Hematol Oncol . 2022 Nov; 15(1):160. PMID: 36319992
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related death worldwide. Countless CRC patients undergo disease progression. As a hallmark of cancer, Warburg...
7.
Zhong X, He X, Wang Y, Hu Z, Yu D, Huang H, et al.
J Immunol Res . 2022 Jul; 2022:9935705. PMID: 35846431
The hypoxic tumor microenvironment and long noncoding RNAs (lncRNAs) are pivotal in cancer progression and correlate with the survival outcome of patients. However, the role of hypoxia-related lncRNAs (HRLs) in...
8.
Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao S, et al.
Cancer Med . 2022 May; 12(1):930-948. PMID: 35616307
Aerobic glycolysis is a common metabolic phenotype in tumors that helps cancer cells adjust to severe living conditions and can aid metastasis in several types of carcinomas, including colorectal cancer...
9.
He X, Zhong X, Hu Z, Zhao S, Wei P, Li D
Clin Transl Med . 2020 Dec; 10(8):e249. PMID: 33377655
Colorectal cancer (CRC) is one of the most common cancers and a leading cause of mortality worldwide. Small extracellular vesicles (sEVs) are nano-sized extracellular vesicles containing a variety of bioactive...
10.
Hu Z, Chang X, Pan Q, Gu K, Okechukwu P
Pharmacogn Mag . 2017 Dec; 13(52):559-565. PMID: 29200713
Background: Camel milk has been reportedly used to treat dropsy, jaundice, tuberculosis, and diabetes while camel urine is used to treat diarrhea and cancer. However, there is no scientific evidence...